Last kr1.18 SEK
Change Today +0.11 / 10.28%
Volume 400.0
IDLB On Other Exchanges
Symbol
Exchange
Stockholm
As of 3:00 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

idl biotech ab- b shares (IDLB) Snapshot

Open
kr1.18
Previous Close
kr1.07
Day High
kr1.18
Day Low
kr1.18
52 Week High
10/3/13 - kr2.70
52 Week Low
09/25/14 - kr0.90
Market Cap
33.7M
Average Volume 10 Days
8.3K
EPS TTM
kr-0.05
Shares Outstanding
27.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IDL BIOTECH AB- B SHARES (IDLB)

Related News

No related news articles were found.

idl biotech ab- b shares (IDLB) Related Businessweek News

No Related Businessweek News Found

idl biotech ab- b shares (IDLB) Details

IDL Biotech AB (publ), a diagnostic company, develops, produces, and markets in vitro diagnostic tests in the areas of oncology and bacteriology worldwide. Its product portfolio comprises TPS for the management of patients with breast, gastrointestinal, ovarian, or prostate cancers; UBC for the management of patients with urinary bladder cancer; and MonoTotal for the management of patients with non-small cell lung cancer. The company also offers TPAcyk for the management of patients with epithelial cell carcinomas; and TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. It distributes its products through a network of business partners primarily in Europe and Asia. The company was formerly known as AB IDL ImmunoDevelopLab and changed its name to IDL Biotech AB (publ) in 1998. IDL Biotech AB (publ) was founded in 1988 and is based in Bromma, Sweden.

Founded in 1988

idl biotech ab- b shares (IDLB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

idl biotech ab- b shares (IDLB) Key Developments

IDL Biotech AB (publ) to Report Q1, 2014 Results on Apr 24, 2014

IDL Biotech AB (publ) announced that they will report Q1, 2014 results on Apr 24, 2014

IDL Biotech AB (publ) to Report Q2, 2014 Sales/Trading Statement Results on Aug 28, 2014

IDL Biotech AB (publ) announced that they will report Q2, 2014 sales/trading statement results on Aug 28, 2014

IDL Biotech AB (publ), Annual General Meeting, May 06, 2014

IDL Biotech AB (publ), Annual General Meeting, May 06, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDLB:SS kr1.18 SEK +0.11

IDLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDLB.
View Industry Companies
 

Industry Analysis

IDLB

Industry Average

Valuation IDLB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 5.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDL BIOTECH AB- B SHARES, please visit www.idl.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.